Image

Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System

Recruiting
18-80 years
Male
Phase N/A

Powered by AI

Overview

Multiparametric MRI of the prostate is recommended before each prostate biopsy. It identifies suspicious areas which will then be the subject of targeted biopsies. However, MRI suffers from low specificity and moderate inter-reader reproducibility, including with the use of the PI-RADS version 2.1 score.

We are developing, within the framework of RHU PERFUSE, a computer-aided diagnosis system (CAD) for the detection of ISUP ≥2 cancers. This system has been trained on a database of patients who had prostate MRI and prostatectomy at the Hospices Civils de Lyon and performed well on a database of patients who had prostate MRI before biopsy at the Hopices civils de Lyon.

However, one of the weaknesses of artificial intelligence systems is their low robustness when tested on MRI images from different manufacturers or institutions.

The goal of the CHANGE study is to build a prospective multicenter cohort of patients who underwent prostate multiparametric MRI followed by systematic and targeted prostate biopsies. The cohort will be used for the final external validation of the CAD developed in PERFUSE.

Eligibility

Inclusion Criteria:

  • Men over 18 years of age
  • Patient with clinical suspicion of prostate cancer referred for a multiparametric MRI of the prostate before a first series of biopsies or before new biopsies after one or more series of negative biopsies
  • PSA ≤ 30 ng / ml
  • Clinical stage ≤ T2c
  • Affiliation or beneficiary of a social security scheme

Exclusion Criteria:

  • Men over 80 years of age
  • PSA> 30 ng / ml
  • Stage T3 or T4 on digital rectal examination
  • Previous prostate biopsy performed within 12 months
  • History of prostate cancer diagnosed by biopsy or endourethral resection.
  • History of pelvic radiotherapy regardless of the cause.
  • History of total or focal treatment for prostate cancer.
  • History of hormone therapy
  • MRI performed more than 3 months before biopsy
  • Prostate MRI performed on a machine other than the center's machines accredited for the study.
  • Presence of a hip prosthesis
  • Contraindication to performing an MRI
  • Contraindication to performing prostate biopsy
  • Patient subject to a legal protection measure or deprived of liberty
  • Subject participating or having participated in interventional medical research with an exclusion period still in progress
  • Misunderstanding of the French language

Study details
    Prostate Cancer

NCT04732156

Hospices Civils de Lyon

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.